Is there a role for new oral anticoagulants as primary and secondary stroke prevention in atrial fibrillation and intracranial stenosis?

Author： Stöllberger Claudia   Bastovansky Adam   Finsterer Josef  

Publisher： Springer Publishing Company

ISSN： 0929-5305

Source： Journal of Thrombosis and Thrombolysis, Vol.36, Iss.4, 2013-11, pp. : 492-494

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Primary and Secondary Stroke Prevention in Nonrheumatic Atrial Fibrillation by Oral Anticoagulation

By  

European Neurology, Vol. 50, Iss. 3, 2003-10 ,pp. : 127-135

Karger

Access to resources Recommend Favorite

Primary Prevention of Ischaemic Stroke in Atrial Fibrillation: New Oral Anticoagulant Drugs for all?

By  

Current Vascular Pharmacology, Vol. 12, Iss. 3, 2014-05 ,pp. : 373-383

Bentham Science Publishers

Access to resources Recommend Favorite

Trials of Novel Oral Anticoagulants for Stroke Prevention In Patients with Non-valvular Atrial Fibrillation

By  

Current Cardiology Reviews, Vol. 10, Iss. 4, 2014-11 ,pp. : 297-302

Bentham Science Publishers

Access to resources Recommend Favorite

Oral Anticoagulants vs. Aspirin for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation: The Verdict is in

By van Walraven C.  

Cardiac Electrophysiology Review, Vol. 7, Iss. 4, 2003-12 ,pp. : 374-378

Springer Publishing Company

Access to resources Recommend Favorite

Prevention of Stroke in Patients with Atrial Fibrillation: The Role of New Antiarrhythmic and Antithrombotic Drugs

By  

Cerebrovascular Diseases, Vol. 30, Iss. 3, 2010-07 ,pp. : 314-322

Karger

Access to resources Recommend Favorite